Oxidative Medicine and Cellular Longevity / 2020 / Article / Fig 4

Research Article

Berberine Attenuates Hyperglycemia by Inhibiting the Hepatic Glucagon Pathway in Diabetic Mice

Figure 4

Effects of BBR on cAMP levels and CREB phosphorylation induced by various agonists. (a) cAMP in hepatocytes after glucagon treatment with and without BBR pretreatment. ##, compared with the none group; , compared with the glucagon group (). (b) cAMP in the liver with and without intravenous glucagon treatment. ##, compared with the none group; , compared with the glucagon group (). (c–e) Primary hepatocytes were preincubated with BBR for 15 min, then stimulated with 1 mM 8-bromo-cAMP (c), 10 μM forskolin (d), or 1 mM IBMX (e) for another 30 min, and protein was analyzed by western blot with the total CREB antibodies and the phospho- (p-) CREB antibody. CREB phosphorylation was normalized to total CREB levels. The data are expressed as the #, compared with the untreated group; , compared with the agonist group ().
(a)
(b)
(c)
(d)
(e)

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.